Image Credit: Getty Images Cory Lappin, OD, MS, FAAO, reviews the clinical performances of perfluorohexyloctane and lotilaner ophthalmic solution, and discusses how the drugs have lived up to ...
The company successfully launched Xdemvy for the treatment of demodex blepharitis in 2024, with revenues surpassing expectations due to strong adoption by eye care providers and favorable payor ...
Advancing TP-04 (lotilaner ophthalmic gel) for the potential treatment of Ocular Rosacea, another large, underserved eye disease with no FDA-approved therapy; Initiation of Phase 2 study planned for ...
Key Laboratory of Chemical Biology (Ministry of Education), NMPA Key Laboratory for Quality Research and Evaluation of Carbohydrate-based Medicine, Department of Pharmacology, School of Pharmaceutical ...
has announced plans to advance TP-04, an investigational ophthalmic gel formulation of lotilaner, for the treatment of Ocular Rosacea, a significant but currently underserved eye condition ...
Advancing TP-04 (lotilaner ophthalmic gel) for the potential treatment of Ocular Rosacea, another large, underserved eye disease with no FDA-approved therapy; Initiation of Phase 2 study planned ...
The Bible's lex talionis—"Eye for eye, tooth for tooth, hand for hand, foot for foot" (Exodus 21:24–27)—has captured the human imagination for millennia. This idea of fairness has been a ...
Joe Biden, 82, believes he could have won reelection if he had stayed in the White House race. In a USA Today interview, he discussed his doubts about serving another term and mentioned regrets about ...